ロード中...
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63
BACKGROUND: Rare prostate carcinomas aberrantly express p63 and have an immunophenotype intermediate between basal and luminal cells. Here, we performed gene expression profiling on p63-expressing prostatic carcinomas and compared them to usual-type adenocarcinoma. We identify ETS2 as highly express...
保存先:
| 出版年: | Prostate |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6818503/ https://ncbi.nlm.nih.gov/pubmed/29761525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23646 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|